Global Infectious Disease Surveillance at DoD Overseas Laboratories, 1999–2007

Abstract

Abstract. The United States Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS) conducted a review in 2008 of projects funded by DoD-GEIS at five partner overseas laboratories from 1999 through 2007. During this period, the annual overseas programming budget grew from US$1.038 million to US$21 million. The review describes the distribution of project priorities and geographic locations over the years, the types of outcomes the projects generated, and the frequency with which they involved collaboration with other public health agencies and organizations, including CDC and WHO. Areas for further program strengthening are identified.

Prevalence and factors influencing the distribution of influenza viruses in Kenya: Seven-year hospital-based surveillance of influenza-like illness (2007–2013)

“…This surveillance system may also provide global benefit through early warning of the circulation of new and dangerous influenza subtypes and local benefits in the event of influenza epidemics. This surveillance system enhanced pandemic preparedness and reporting capabilities required by the 2005 International Health Regulations (IHR) [8]. At the same time, other sentinel influenza systems were also put in place by the MoH with technical support from the Centers for Disease Control and Prevention-Kenya (CDC-K) [9].…”

The Global Emerging Infection Surveillance and Response System (GEIS), a U.S. government tool for improved global biosurveillance: a review of 2009

“…DoD has a long history of medical research and development, much of which has been performed through a network of overseas laboratories. Although their geographic locations have changed through time, five laboratories were in operation in 2009: Cairo, Egypt; Nairobi, Kenya; Bangkok, Thailand; Lima, Peru; and Jakarta, Indonesia in 2009 (Figure 1 ) [ 3 ]. Historically, the role of these laboratories was limited almost exclusively to the research and development of products, such as vaccines, antimicrobials or diagnostics, that would benefit the health of DoD forces throughout the world.…”